Sarah L Anderson

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. doi request reprint Implementation of a clinical pharmacy specialist-managed telephonic hospital discharge follow-up program in a patient-centered medical home
    Sarah L Anderson
    University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado 80045, USA
    Popul Health Manag 16:235-41. 2013
  2. doi request reprint Determining predictors of response to exenatide in type 2 diabetes
    Sarah L Anderson
    School of Pharmacy, University of Colorado, 12850 E Montview Blvd, Aurora, CO 80045, USA
    J Am Pharm Assoc (2003) 52:466-71. 2012
  3. doi request reprint Dapagliflozin for the treatment of type 2 diabetes
    Sarah L Anderson
    University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
    Ann Pharmacother 46:590-8. 2012
  4. doi request reprint Association of pancreatitis with glucagon-like peptide-1 agonist use
    Sarah L Anderson
    School of Pharmacy, University of Colorado Denver, Aurora, CO 80045, USA
    Ann Pharmacother 44:904-9. 2010

Detail Information

Publications4

  1. doi request reprint Implementation of a clinical pharmacy specialist-managed telephonic hospital discharge follow-up program in a patient-centered medical home
    Sarah L Anderson
    University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado 80045, USA
    Popul Health Manag 16:235-41. 2013
    ..01) compared to those who were not contacted. Institutions should consider allocating resources for pharmacist-managed posthospital discharge follow-up services because of the potential for positive clinical and financial impact...
  2. doi request reprint Determining predictors of response to exenatide in type 2 diabetes
    Sarah L Anderson
    School of Pharmacy, University of Colorado, 12850 E Montview Blvd, Aurora, CO 80045, USA
    J Am Pharm Assoc (2003) 52:466-71. 2012
    ..To determine predictors of glycemic response to exenatide and to assess change in glycosylated hemoglobin (A1C) and whether a correlation exists between weight loss and glycemic response...
  3. doi request reprint Dapagliflozin for the treatment of type 2 diabetes
    Sarah L Anderson
    University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
    Ann Pharmacother 46:590-8. 2012
    ....
  4. doi request reprint Association of pancreatitis with glucagon-like peptide-1 agonist use
    Sarah L Anderson
    School of Pharmacy, University of Colorado Denver, Aurora, CO 80045, USA
    Ann Pharmacother 44:904-9. 2010
    ..To review the possible association between glucagon-like peptide-1 (GLP-1) agonist use and pancreatitis in patients with type 2 diabetes mellitus...